Book Value per Share: dianthustx.com (DNTH)

Graphic logo of Dianthus Therapeutics (DNTH)

Dianthus Therapeutics (DNTH) laboratories are operating normally, ensuring antibody synthesis through the modernized facilities of its partners. Meanwhile, the business strictly adheres to ESG principles by implementing eco-friendly reagent disposal methods. The stock price action shown below is recorded at 21.23. The operating model relies on deep outsourcing: Dianthus Therapeutics (DNTH) delegates all clinical trials and drug production to external contractors, resulting in a critical dependence on third-party vendors.

Dianthus Therapeutics Inc (DNTH): Share Book Value from 02/21/2024 to 10/28/2026

dianthustx.com - analytical breakdowns and key metrics (DNTH)

- price and consensus price forecast:
Stock Quotes Dianthus Pharma|DNTH - Analyst Forecast Prices
- market capitalization data:
Market Capitalization Dianthus Therapeutics, Inc.|DNTH - Value Adjusted for Debt and Cash
- book capitalization data:
Net Assets per Single Share Dianthus Therapeutics|DNTH - Net Asset Value|Market Capitalization to Book Value Ratio dianthustx.com|DNTH - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Dianthus Therapeutics|DNTH - Long-Term Debt to Capital|Short-Term Debt to Equity Dianthus Therapeutics, Inc.|DNTH - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Dianthus Therapeutics, Inc.
Fundamental company valuation:Dianthus Pharma - DNTH
Manufactured products of Dianthus Therapeutics, Inc.

Book value per share determines the portion of equity attributable to a single security. This metric is calculated by dividing net assets by the number of shares outstanding, reflecting the intrinsic value of the business. By analyzing the calculated book value per share, an investor can track the trend of resource accumulation. For Dianthus Therapeutics (DNTH), the growth of this metric is driven by R&D capitalization; however, a high reliance on external contractors (CRO/CMO) makes the asset structure less tangible.

Competitors of Dianthus Therapeutics (DNTH)

Accounting Value per Share Argenx ARGX|BNTX - Book Price of a Share|Book Value per Share Abivax Corp ABVX|ADMA (admabiologics.com) - Accounting Value of a Share|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Grifols Biemat (GRFS)|Book Value per Share ADPT (Adaptive Biotechnologies)|celldex.com - Book Value per Share|Net Assets per Single Share Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Accounting Value of a Share|VERA (Vera Pharma) - Net Assets per Single Share|Pharvaris Pharma (PHVS) - Accounting Value per Share|ABCL (AbCellera Biologics Inc) - Book Value per Share|Book Value per Share tourmalinebio.com (TRML)|Precigen (PGEN) - Accounting Value per Share|Accounting Value of a Share Pharming Group NV (PHAR)|Book Value per Share NKTR|Upstream Pharma - Net Assets per Share|ZBIO: Net Assets per Single Share|IMNM: Accounting Value per Share|GOSS (Gossamer Bio) - Net Assets per Single Share|Accounting Value per Share KalVista Pharma|SEPN (Septerna Corp) - Accounting Value per Share|Book Value per Share PVLA|Net Assets per Single Share Savara Inc. SVRA|Equity per Share rigel.com (RIGL)|ANAB: Book Value per Share|Net Asset Value per Share Astria Therapeutics Inc ATXS|enGene Bio (ENGN) - Book Value per Share|RAPT - Equity per Share|aerovatetx.com - Book Value per Share|aclaristx.com (ACRS) - Net Assets per Share|KYTX (Kyverna Therapeutics, Inc.) - Book Value per Share|Book Value per Share TLSA|Net Assets per Single Share Cabaletta Bio, Inc CABA|Equity per Share Ventyx Biosciences, Inc VTYX|Accounting Value per Share Theratechnologies Inc. (THTX)|Book Price of a Share avalotx.com AVTX|Book Value per Share Eledon Pharmaceuticals, Inc. (ELDN)|Agenus, Inc. (AGEN) - Accounting Value of a Share|CLYM: Accounting Value per Share|ZURA (Zura Bio Ltd) - Book Value per Share|ATYR: Net Assets per Single Share|Net Assets per Share Adagene Corp (ADAG)|ImageneBio Inc (IMA) - Accounting Value per Share|Accounting Value of a Share shattucklabs.com STTK|Accounting Value per Share Equillium (EQ)|Book Price of a Share Connect Biopharma Holdings CNTB|Book Value per Share Immunic Inc (IMUX)|ATRA - Accounting Value of a Share|Book Value per Share IFRX|XFOR (X4 Pharmaceuticals Inc.) - Net Asset Value per Share|ACET - Net Assets per Single Share|Accounting Value of a Share Celularity Corp|Book Value per Share INMB|Book Value per Share BRNS (barinthusbio.com)|Kezar Life Sciences, Inc. (KZR) - Net Assets per Single Share|Share Book Value SAB Biotherapeutics Inc. SABS|AKTX (Akari Therapeutics plc) - Book Value per Share|Enlivex Therapeutics (ENLV) - Net Asset Value per Share|QTTB: Accounting Value per Share|Book Value per Share geovax.com|Edesa Biotech (EDSA) - Accounting Value per Share|Book Price of a Share iBio Inc|CARM (Carisma Therapeutics) - Book Value per Share|Net Assets per Share XTL Bio (XTLB)|Bolt Biotherapeutics, Inc. - Book Value per Share|HCW Biologics, Inc. - Accounting Value per Share|Net Assets per Single Share APVO (Aptevo)|AIM - Net Assets per Share|Book Value per Share aditxt.com|GRI (GRI Bio Corporation) - Equity per Share|Net Assets per Single Share XORTX Therapeutics Inc. (XRTX)|Equity per Share reshapelifesciences.com (HIND)|Accounting Value per Share Revelation Biosciences, Inc.|Book Price of a Share Indaptus Therapeutics Inc (INDP)|Book Value per Share Scinai|CalciMedica Inc - Accounting Value of a Share|Net Assets per Single Share Affimed Therapeutics|ALLK - Share Book Value|Book Value per Share hookipapharma.com HOOK|IGM Biosciences (IGMS) - Accounting Value of a Share|ITOS (iTeos) - Book Value per Share|Book Value per Share OCEA|TC Biopharm (TCBP) - Net Assets per Single Share|Accounting Value of a Share THRD (thirdharmonicbio.com)